| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |